Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis

Chadrick E. Lane; Michelle L. Conroy

doi:10.1007/978-3-030-94960-0_53

Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In this study, the investigators evaluated the efficacy and safety data from a meta-analysis of randomized, double-blind, placebo-controlled, parallel-group trials of acetylcholinesterase inhibitors (ChEIs) in the treatment of clinically diagnosed Alzheimer’s disease (AD).

Original language	English (US)
Title of host publication	Essential Reviews in Geriatric Psychiatry
Publisher	Springer International Publishing
Pages	303-306
Number of pages	4
ISBN (Electronic)	9783030949600
ISBN (Print)	9783030949594
DOIs	https://doi.org/10.1007/978-3-030-94960-0_53
State	Published - Jan 1 2022

Keywords

Acetylcholinesterase inhibitor
Alzheimer’s disease
Double-blind
Efficacy
Placebo-controlled
Randomized
Safety

ASJC Scopus subject areas

General Medicine
General Psychology

Access to Document

10.1007/978-3-030-94960-0_53

Cite this

@inbook{d0e2b5b0d5874906ba299f8a5d2cb165,

title = "Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer{\textquoteright}s Disease: A Meta-analysis",

abstract = "In this study, the investigators evaluated the efficacy and safety data from a meta-analysis of randomized, double-blind, placebo-controlled, parallel-group trials of acetylcholinesterase inhibitors (ChEIs) in the treatment of clinically diagnosed Alzheimer{\textquoteright}s disease (AD).",

keywords = "Acetylcholinesterase inhibitor, Alzheimer{\textquoteright}s disease, Double-blind, Efficacy, Placebo-controlled, Randomized, Safety",

author = "Lane, {Chadrick E.} and Conroy, {Michelle L.}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-94960-0_53",

language = "English (US)",

isbn = "9783030949594",

pages = "303--306",

booktitle = "Essential Reviews in Geriatric Psychiatry",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease

T2 - A Meta-analysis

AU - Lane, Chadrick E.

AU - Conroy, Michelle L.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - In this study, the investigators evaluated the efficacy and safety data from a meta-analysis of randomized, double-blind, placebo-controlled, parallel-group trials of acetylcholinesterase inhibitors (ChEIs) in the treatment of clinically diagnosed Alzheimer’s disease (AD).

AB - In this study, the investigators evaluated the efficacy and safety data from a meta-analysis of randomized, double-blind, placebo-controlled, parallel-group trials of acetylcholinesterase inhibitors (ChEIs) in the treatment of clinically diagnosed Alzheimer’s disease (AD).

KW - Acetylcholinesterase inhibitor

KW - Alzheimer’s disease

KW - Double-blind

KW - Efficacy

KW - Placebo-controlled

KW - Randomized

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=85159003407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159003407&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-94960-0_53

DO - 10.1007/978-3-030-94960-0_53

M3 - Chapter

AN - SCOPUS:85159003407

SN - 9783030949594

SP - 303

EP - 306

BT - Essential Reviews in Geriatric Psychiatry

PB - Springer International Publishing

ER -

Efficacy and Safety of Cholinesterase Inhibitors in Alzheimer’s Disease: A Meta-analysis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this